Drug Maker Responds to Allegations Asserted in Remicade Injury Case

EAST BRUNSWICK, N.J. - Claims asserted by a man who allegedly sustained injuries as a result of using Remicade are barred by the New Jersey Products Liability Act and preempted by the federal law, the manufacturer stated in response to the man's lawsuit. Randall E. Miller and Martha H. Miller v. Centocor, Inc., et al., MID-L-3099-03 (N.J. Sup. Ct., Middlesex Cty.).

Centocor, Inc., the company that makes the rheumatoid arthritis treatment, further argued in the July 3 answer that the case should be dismissed on forum non conveniens grounds because the plaintiff resides in Alabama and the suit was filed …